
P&F secures FDA approval for TRICAV II pivotal clinical trial for severe tricuspid regurgitation
TRICAV II will evaluate the safety and effectiveness of the TricValve® Transcatheter Bicaval Valve System Wilmington, Delaware, Dec. 12, 2025 — P&F USA, Inc., the U.S. subsidiary of global heart valve manufacturer P&F Products and Features GmbH, today announced that the U.S. Food and Drug

